These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6446012)

  • 1. Circadian rhythmicity of prolactin secretion in Huntington's chorea.
    Polleri A; Savoldi F; Muratorio A; Masturzo P; Murialdo G; Martignoni E; Nappi G; Iudice A; Murri L
    Life Sci; 1980 May; 26(19):1609-17. PubMed ID: 6446012
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian periodicity of plasma prolactin in some neurological diseases.
    Ferrari E; Nappi G; Vailati A; Martignoni E; Bossolo PA; Polleri A
    Int J Chronobiol; 1979; 6(4):231-42. PubMed ID: 162341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
    Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Caine E; Kartzinel R; Ebert M; Carter AC
    Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone and prolactin release in Huntington's chorea.
    Chalmers RJ; Johnson RH; Nanda RN
    Lancet; 1977 Oct; 2(8042):824. PubMed ID: 71631
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin control in Huntington's chorea.
    Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
    Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone and prolactin secretion in Huntington's disease.
    Levy CL; Carlson HE; Sowers JR; Goodlett RE; Tourtellotte WW; Hershman JM
    Life Sci; 1979 Feb; 24(8):743-9. PubMed ID: 155768
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
    Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
    J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EEG in Huntington's chorea: a clinical and neuropathological study.
    Scott DF; Heathfield KW; Toone B; Margerison JH
    J Neurol Neurosurg Psychiatry; 1972 Feb; 35(1):97-102. PubMed ID: 4260288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin.
    Chang RJ; Davidson BJ; Carlson HE; Judd HL
    Am J Obstet Gynecol; 1982 Oct; 144(4):402-7. PubMed ID: 7124858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
    Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
    Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Bellosta Diago E; Pérez Pérez J; Santos Lasaosa S; Viloria Alebesque A; Martínez Horta S; Kulisevsky J; López Del Val J
    Parkinsonism Relat Disord; 2017 Nov; 44():95-100. PubMed ID: 28935191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythms of melatonin and cortisol in manifest Huntington's disease and in acute cortical ischemic stroke.
    Adamczak-Ratajczak A; Kupsz J; Owecki M; Zielonka D; Sowinska A; Checinska-Maciejewska Z; Krauss H; Michalak S; Gibas-Dorna M
    J Physiol Pharmacol; 2017 Aug; 68(4):539-546. PubMed ID: 29151070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electromyographic silent period in Huntington's chorea--a comparison between childhood and adult values.
    Sandyk R
    S Afr Med J; 1982 Feb; 61(9):316-7. PubMed ID: 6460326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease.
    Cuesta M; Aungier J; Morton AJ
    Neurobiol Dis; 2012 Jan; 45(1):145-55. PubMed ID: 21820053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's chorea. A random process.
    Tan BK; Mastebroek HA; Zaagman WH
    Clin Neurol Neurosurg; 1976; 79(3):215-21. PubMed ID: 141992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.